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Vulvo-vaginal candidiasis (VVC) is a common condition in human immunodeficiency virus (HIV)-
infected women. Toll-like receptor (TLR) 2 and TLR4 are key pattern-recognition receptors of the innate 
immune system in sensing Candida albicans. The aim of this study was to assess the expression of 
TLR2 and TLR4 signaling pathways in HIV-infected and uninfected women with VVC. Cervico-vaginal 
fluids (CVF) were obtained from 7 HIV infected and 11 HIV uninfected clinic attendees in KwaZulu-Natal 
between June, 2011 and December, 2011. VVC was diagnosed clinically and confirmed by Gram stain 
and culture of genital samples. Monocytes were isolated from a healthy adult volunteer, pre-incubated 
with anti-TLR2, anti-TLR4 and a combination of anti-TLR2/anti-TLR4 monoclonal antibodies. Monocytes 
were then stimulated by CVF. Levels of cytokines were measured by Luminex® multiplex 
immunoassays. Compared with baseline concentrations, stimulation with CVF of HIV+VVC+ women 
post-TLR2 blockage increased IL-6, IL-10 and IL-13 production by 165.5, 162.5 and 106.7%, respectively. 
Using paired T-tests, there was a significant difference in the increase of the concentrations of IL-6 (P = 
0.04), IL-10 (P = 0.003), and IL-13 (P = 0.031) when comparing stimulation by CVF of HIV+VVC+ versus 
stimulation by CVF of HIV-VVC+ patients. There was a linear correlation between genital HIV RNA loads 
and mean level production of IL-6 (r = 0.722; R
2
 = 0.679; P = 0.067) as well as IL-8 (r = 0.910; R
2
 = 0.833; P 
= 0.004). Findings suggest potential roles of TLR2 in the pathogenesis of VVC among HIV-infected 
women. 
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seen to be frequent and less effectively responsive to 
conventional anti-fungal therapy. Reasons are not well 
understood. Candida albicans has been reported as the 
cause of VVC in 85 to 95% of cases (Sobel, 2007). The 
cell wall of C. albicans is composed of pathogen-associa-
ted molecular patterns (PAMPs), especially poly-
saccharides like chitin, 1,3-β-glucans and 1,6-β-glucans 
and proteins that are heavily mannosylated with mannan 
side-chains. 
Pathogen recognition receptors (PRRs), such as the 
toll-like receptors (TLRs) and C-type lectins (CLRs) on 
the surface of antigen presenting cells (APCs) are able to 
recognize PAMPs. Studies have shown that TLR2 
recognizes phospholipomannans; TLR4 recognizes O-
linked mannans and macrophage mannose receptor 
(MMR) recognizes N-linked mannans (Jouault et al., 
2003). Whilst the CLR dectin-1 recognizes β-glucan, CLR 
dectin-2 recognizes mannose residues (McGreal et al., 
2006; Brown and Gordon, 2001). 
Immune cell populations involved in recognition of C. 
albicans during the innate immune response include 
monocytes, macrophages and neutrophils. Dendritic cells 
are crucial for processing of and antigen presentation to 
T cells, and therefore for activation of specific immunity. 
This recognition of C.albicans by immune cells is done 
mainly through TLRs. The latter are involved in 
inflammatory responses induced by C. albicans, of which 
TLR2 and TLR4 are the most studied (Jouault et al., 
2003). They are expressed by monocytes, macrophages, 
dendritic cells, neutrophils, CD4+ T cells and epithelial 
cells (Weindl et al., 2007). Studies have shown that the 
activation of TLR2 signal pathways in these antigen-
presenting cells (APCs) by ligation of C. albicans cell-wall 
components such as phospholipomannan leads to the 
production of cytokines that are able to induce a Th2 
cellular response (Weindl et al., 2007; Weis et al., 1998; 
Bellocchio et al., 2004; Miyazato et al., 2009). Hence, 
blocking TLR2 with a TLR2-specific antibody before 
stimulation of monocytes by C. albicans was shown to 
result in diminished release of Th2-associated cytokines 
(van de Veerdonk et al., 2008). In contrary, the activation 
of TLR4 signal pathways during candidiasis will result in 
the production of cytokines able to induce a Th1 cellular 
response. Mannans of C. albicans are recognized by 
TLR4 leading to the production of pro-inflammatory 
cytokines (Roeder et al., 2004). 
It is however unclear whether immune changes 
observed at vaginal mucosal surfaces of HIV infected 
women interfere with the pattern recognition process of 
C. albicans by  innate  immune  cells. Hence,  the  aim  of  
 




this study was to assess the expression of TLR2 and 
TLR4 on monocytes following stimulations by genital 
secretions of HIV infected and uninfected women 
presented with symptomatic VVC. We hypothesized that 
HIV infection alters TLR2 (but not TLR4) dependent 
responses to Candida antigens by monocytes, resulting 
in symptomatic VVC.  
 
 




A total of 18 women (7 HIV-infected and 11 HIV-uninfected), aged 
≥18 years, all black Africans, attending Umlazi D clinic, a primary 
healthcare facility in KwaZulu-Natal between June, 2011 and 
December, 2011, were consecutively enrolled by informed consent.  
Patients aged < 18 years as well as those menstruating or having 
visible blood contamination of genital samples were excluded. All 
patients presented initially with signs and symptoms suggestive of 
lower genital tract infections (LGTIs) and were thereafter screened 
for the presence of LGTIs caused by Chlamydia trachomatis, 
Neisseria gonorrhoeae, Mycoplama genitalium, Trichomonas 
vaginalis, herpes simplex virus type 2 and bacterial vaginosis as 
described elsewhere (Zimba et al., 2011; Apalata et al., 2009). The 
selected 18 participants were retained in the study because they 
were free from the aetiological agents causing LGTIs. The study 
was approved by the Biomedical Research Ethics Committee of the 
University of KwaZulu-Natal (Ref. BE 224/11).  
 
 
Diagnostic criteria of symptomatic vulvo-vaginal candidiasis 
 
Vaginal swab (Becton Dickinson) taken from the anterior fornix was 
directly plated onto Sabouraud Dextrose agar with chloramphenicol 
(BBL
TM
 Becton Dickinson) and incubated at 29°C, 48 h to estimate 
the relative vaginal fungal burden. The numbers of yeast colonies 
were recorded as the number of colonies per plate (Sherrard et al., 
2011). Cases of symptomatic VVC were defined according to 
clinical and laboratory criteria as described by the 2011 European 
(IUSTI/WHO) guideline on the management of vaginal discharge 




Isolation of monocytes from peripheral human blood   
 
Using Histopaque® 1077 and Histopaque® 1119 (Sigma-Aldrich
®
) 
per manufacturer’s instructions, we isolated neutrophils and 
monocytes from fresh human blood collected from a healthy donor 
(neutrophils were used for other experiments not discussed here) 
(Rubin-Bejerano et al., 2003). After centrifugation and different 
wash steps, the peripheral blood mononuclear cells (PBMCs) 
appeared as a dense white band above the Histopaque® 1077 and 
granulocyte layer. This was removed with a 5 ml plastic pipette. 
Monocytes were separated from lymphocytes on the basis of their 
differential adherence to plastic (Rubin-Bejerano et al.,  2003).  The
*Corresponding author. E-mail: 203520405@stu.ukzn.ac.za. Tel: + 27 31 260 4395. Fax: +27 31 260 4431 
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cells were finally resuspended into 2 ml RPMI-1640 medium 
supplemented with D-glutamate (HiMedia Laboratories, Mumbai, 
India). The cell count was done using the dye exclusion test. Briefly, 
a total of 90 μl of isotonic phosphate buffered saline (PBS; Oxoid 
Limited Basingstoke, UK) (pH = 6.9) and 10 μl of monocytes was 
mixed and added to 100 μl of Trypan blue solution, 0.4% (Gibco®). 
The number of cells was counted with a haemocytometer under an 





Collection of and stimulation of monocytes with cervico-
vaginal fluids (CVF)  
 
A vaginal tampon (8 Ks), Tampax Regular® (Compak) was inserted 
into the vagina, left in situ for 3 min and then placed into a sterile 
container containing 10 ml of phosphate buffered saline (PBS; 
Oxoid Limited Basingstoke, UK) (pH = 6.9). Vaginal fluid was 
expressed using an autoclaved wooden tongue depressor and 
filtered through a 0.22 μm Costar Spin-X cellulose acetate filter 
membranes (Sigma).  
In testing the roles of TLR 2 and TLR 4, monocytes were pre-
incubated (1 h at 37°C) separately with anti-TLR2 (Abcam®) and 
anti-TLR4 (Abcam®) specific monoclonal antibodies before stimu-
lation with CVF or sterile normal saline (negative control) into 96 
wells tissue culture plates. A total of 500 µl of 1 × 10
6 
monocytes/ml 
were pre-incubated with anti-TLR2 (50 µl). Another 500 µl of 1 × 10
6 
monocytes/ml were pre-incubated with anti-TLR 4 (50 µl). Another 
500 µl of 1 × 10
6 
monocytes/ml were pre-incubated with a mixture of 
50 µl of anti-TLR 2 and 50 µl of anti-TLR 4 antibodies. We also 
used 500 µl of 1 × 10
6 
monocytes/ml pre-incubated with 50 µl of 
sterile normal saline (no anti-TLR antibodies) as controls.  At the 
end of the pre-incubation period, 50 µl of 1 × 10
6 
monocytes/ml 
were mixed with 50 µl of CVF obtained from HIV infected and HIV 
uninfected women diagnosed with symptomatic VVC. The mixture 
was incubated into 96 wells plate at 37°C and supernatant was 
collected after 4 and 24 h following stimulation in order to measure 
cytokines and chemokines. 
 
 
Measurement of cytokines/chemokines  
 
Concentrations (in pg/ml) of IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, 
IL-10, IL-12, IL-13, IL-17, G-CSF, GM-CSF, IFN-γ, MCP-1, MIP-1β, 
TNF-α, TGF-β1, TGF-β2 and TGF-β3 were measured by a 
multiplex microbead system (Invitrogen, UK) using a Luminex 
platform. Multiplex cytokine fluorescent bead-based immunoassays 
were performed using two different commercially available multi-
plex luminex kits: Bio-plex pro human cytokine 17-plex assay and 
Bio-plex pro TGF-β 3-plex assay (Bio-Rad Laboratories, Inc., 
Parkwood). The assay sensitivity or limit of detection (pg/ml) was: 
IL-1β (0.6), IL-2 (1.6), IL-4 (0.7), IL-5 (0.6), IL-6 (2.6), IL-7 (1.1), IL-8 
(1.0), IL-10 (0.3), IL-12 (3.5), IL-13 (0.7), IL-17 (3.3), G-CSF (1.7), 
GM-CSF (2.2), IFN-γ (6.4), MCP-1 (1.1), MIP-1β (2.4), TNF-α (6), 
TGF-β1, TGF-β2 and TGF-β3; and a 5 PL regression formula was 
used to calculate cytokine/chemokine concentrations from the 
standard curves (Bio-Plex Manager software, version 4). Cytokine/ 
chemokine concentrations below the lower limit of detection were 
reported as the midpoint between the lowest concentrations 





Data were expressed as means ± standard error of the mean 





for the categorical variables. When data were normally distributed, 
analysis of the variance (ANOVA) was used to examine differences 
between groups. However, non-parametric Mann-Whitney U or 
Kruskal-Wallis tests were used when data were asymmetrically 
distributed. Multiple comparisons of means of cytokine/chemokine 
levels displaying significant differences in univariate analyses 
across the study groups were performed using Post Hoc Bonferroni 
pairwise tests considering a type I error rate of 0.05. For normally 
distributed variables, Paired T-tests were used to determine if two 
sets of variables were significantly different from each other. Data 
were analysed using SPSS
®
 statistical software version 21.0 (SPSS 
Inc; Chicago, IL). All tests were two sided and a p value < 0.05 was 





Of the 18 participants, symptomatic VVC was diagnosed 
from 7/7 (100%) of HIV infected and 6/11 (54.5%) of HIV 
uninfected women. Following blockage of TLR2 with an 
anti-TLR2 monoclonal antibody, monocytes were 
stimulated with CVF of HIV-VVC-, HIV-VVC+ and 
HIV+VVC+ women. Table 1 depicts the mean concentra-
tions of cytokines/chemokines displaying significant 
differences across those 3 study groups. Bonferroni 
multiple comparison tests were performed for variables 
that showed significant univariate associations (Table 1). 
Of the 5 cytokines that showed significant differences 
across the study groups, 2 anti-inflammatory (IL-10 and 
IL-13) and 1 pro-inflammatory (IL-6) cytokines were 
confirmed by Bonferroni tests. The mean level of IL-6 
was significantly higher in HIV+VVC+ group as compared 
to HIV-VVC+ group (P = 0.03). In addition, there were 
significantly higher mean levels of IL-10 (P = 0.003) and 
IL-13 (P = 0.019) in HIV+VVC+ group as compared to 
HIV-VVC- group.  
Compared with baseline concentrations, stimulation 
with CVF of HIV+VVC+ women post-TLR2 blockage 
increased IL-6, IL-10 and IL-13 production by 165.5, 
162.5 and 106.7%, respectively (Figure 1). However, 
stimulation with CVF of HIV-VVC+ women only increased 
IL-6, IL-10 and IL-13 by 36.8, 65.9 and 66.7%, 
respectively (Figure 2). Using paired T-tests, there was a 
significant difference in the increase of the concentrations 
of IL-6 (P = 0.04), IL-10 (P = 0.003) and IL-13 (P = 0.031) 
when comparing stimulation by CVF of HIV+VVC+ versus 
stimulation by CVF of HIV-VVC+ patients. Stimulation 
post-TLR4 blockage by CVF of HIV-VVC+ and CVF of 
HIV+VVC+ women did not show significant differences of 
the mean concentrations of all tested cytokines across 
the study groups. After blocking TLR2 and TLR4 
simultaneously with specific monoclonal antibodies, only 
IL-6, IL-10 and IL-13 were significantly increased when 
monocytes were stimulated with CVF of HIV+VVC+ as 
depicted in Figure 3.  Findings also showed a linear 
correlation between genital HIV RNA loads and mean 
level production of IL-6 (r = 0.722; R
2
 = 0.679;  P = 0.067)  
 
 




Table 1. Comparison of cytokinr/chemokine mean levels across the groups post-LTR2 blockage. 
 
Variable 
Study group (mean ± SEM) 
 P value 
HIV- and VVC- (n=5) HIV- and VVC+ (n=6) HIV+ and VVC+ (n=7) 
Anti-inflamatory      
IL-10 0.02±0.001 0.42±0.12 0.69±0.12  0.001 
IL-13 0.15±0.001 0.25±0.001 0.31±0.04  0.019 
TGF-β2** 60±0.001 47.37±4.23 51.6±1.69  0.021 
      
Pro-inflamatory      
IL-6 0.35±0.001 0.26±0.08 0.77±0.16  0.021 












Figure 2. Variations of cytokine levels in HIV uninfected women. 
 
 










as well as IL-8 (r = 0.910; R
2





Findings from this study have shown that blocking TLR2 
with TLR2-specific antibody followed by stimulation of 
monocytes with CVF of HIV-infected women who were 
also co-infected with symptomatic VVC resulted in higher 
increase in the concentrations of IL-6, IL-10 and IL-13. 
HIV+VVC+ patients produced unusually high levels of 
one inflammatory cytokine (IL-6) and 2 potent anti-
inflammatory cytokines (IL-10, IL-13). 
Studies in mice have shown that the development of 
protective anticandidal Th1 responses requires the 
concerted actions of several pro-inflammatory cytokines 
in the relative absence of inhibitory Th2 cytokines, such 
as IL-4 and IL-10, which inhibit development of Th1 
responses (Tonnetti et al., 1995). In the present study we 
found that despite increased mean levels of IL6, there 
was a parallel excess production of IL-10 and IL-13 post-
TLR2 blockage. These findings confirm that in HIV-
infected patients, Th1 activation results in phagocyte-
dependent immunity and might represent an important 
mechanism of anticandidal resistance; but subsequent 
Th2 reactivity, triggered by Candida infection would be 
mostly associated with the pathology (Romani et al., 
1995). This can suggest that Th2 reactivity overcame the 
Th1 responses in HIV positive women leading to 
candidiasis. Thus, the Th cell dichotomy to Candida may 
have important implications particularly in contributing to 
the dominance of Th2  responses  in  cases  of  recurrent 
VVC observed among HIV positive women (Romani et 
al., 1995).   
IL-13 is recognized for its effects on monocytes, where 
it upregulates class II expression, promotes IgE class 
switching and inhibits inflammatory cytokine production. 
In general, activation of TLR2 signal pathways during 
candidiasis should lead to the production of Th2 
cytokines, thus blocking TLR2 with a TLR2-specific 
monoclonal antibody followed by stimulation of 
monocytes by C. albicans should result in diminished 
release of these Th2 cytokines. Netea et al. (2004) 
showed that TLR2
-/-
 mice are more resistant to 
disseminated Candida infection and this is associated 
with increased chemotaxis and enhanced candidacidal 
capacity of TLR2
-/-
 monocytes/macrophages. Whilst the 
production of pro-inflammatory cytokines can be normal, 
levels of anti-inflammatory cytokines are severely 
impaired in the TLR2
-/-
 mice. The authors found that this 
was accompanied by a substantial decrease in the 
CD4+CD25+ regulatory T (Treg) cell population in TLR2
-/-
 
mice (Netea et al., 2004). Furthermore, in vitro studies 
confirmed that enhanced survival of Treg cells was 
induced by TLR2 agonists; C. albicans induces 
immunosuppression through TLR2-derived signals that 
mediate increased anti-inflammatory cytokine (that is, IL-
10) production and survival of Treg cells, playing a critical 












individuals, there might be an upregulation of TLR2 
during stimulation of monocytes by Candida spp. leading 
to an over production of anti-inflammatory cytokines. This 
might suggest an underlying role played by Th2/Treg cell 





The limitation of this study is mainly the small sample 
size that might not allow generalization of our findings. A 
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